logo

For the Inventor, By the Inventor

Weesp, Netherlands

Derk Hamminga

USPTO Granted Patents = 15

Average Co-Inventor Count = 3.4

ph-index = 9

Forward Citations = 254(Granted Patents)


Company Filing History:

goldMedal15 out of 169 
 
Duphar International Research Bv
 patents

Years Active: 1990-1994

Loading Chart...
15 patents (USPTO):Explore Patents
1. 5332746 - 8,9-annelated-.beta.-carbolines and 8,9-annelated (1994-07-26),
2. 5328905 - 8,9-anellated-1,2,3,4-tetrahydro-.beta.-carboline derivatives (1994-07-12),
3. 5326768 - 3,4-annelated benzimidazol-2-(1H)-one 1-carboxylic acid derivatives (1994-07-05),
4. 5223625 - Annelated indolo [3,2,-C]lactams (1993-06-29),
5. 5198437 - 1,7-annelated indolecarboxylic acid esters and amides (1993-03-30),
6. 5183822 - Substituted 3,4-annelated benzimidazol-2(1H)-ones (1993-02-02),
7. 5102901 - New 3-N substituted carbamoyl-indole derivatives (1992-04-07),
8. 5100884 - 8,9-aneallated-1,2,3,4-tetrahydro-.beta.-carboline derivatives (1992-03-31),
9. 5066649 - 8,9-annelated-1,2,3,4-tetrahydro-.beta.-carboline derivatives (1991-11-19),
10. 5049563 - Annelated indoleketones with an imidazolylalkyl substituent (1991-09-17),
11. 5037844 - Substituted 1H-indazole-3-carboxamides (1991-08-06),
12. 4985424 - Certain substituted 1,7-annelated 1h-indazoles being selective (1991-01-15),
13. 4985420 - 1,7-annelated indolecarboxylic acid esters and -amides (1991-01-15),
14. 4950759 - Substituted 1,7-annelated 1H-indazoles (1990-08-21),
15. 4939136 - New anellated indole derivatives (1990-07-03),

Certainly! Here is an article about inventor Derk Hamminga:

Title: Unveiling the Innovations of Derk Hamminga

Introduction

Derk Hamminga, a prolific inventor hailing from Weesp, Netherlands, has made significant contributions in the field of pharmaceuticals with a noteworthy portfolio of 15 patents. His groundbreaking work has centered around the development of novel compounds with remarkable fibrinolytic properties, paving the way for advancements in oral fibrinolytics.

Latest Patents

Among his latest patents, Derk Hamminga has introduced 8,9-annelated-.beta.-carbolines and 8,9-annelated-3,4-dihydro-.beta.-carbolines. These compounds, characterized by their unique molecular structures, exhibit promising fibrinolytic capabilities and can serve as effective orally active fibrinolytics. The formulations hold great potential for addressing blood clot-related disorders, showcasing Hamminga's ingenuity in pharmaceutical innovation.

Career Highlights

Derk Hamminga is associated with Duphar International Research Bv, a renowned player in the pharmaceutical industry. Through his tenure at the company, he has spearheaded numerous research initiatives and patent applications, solidifying his reputation as a leading inventor in the realm of pharmaceutical sciences.

Collaborations

In his pursuit of excellence, Derk Hamminga has collaborated with esteemed professionals in the field, including his colleagues Ineke van Wijngaarden and Wouter Wouters. Together, they have synergized their expertise to drive forward innovative research projects and patent developments, underscoring the power of collaboration in fostering groundbreaking inventions.

Conclusion

Derk Hamminga's contributions to the realm of pharmaceutical innovations have been nothing short of remarkable. His inventive spirit, coupled with a dedication to advancing healthcare solutions, has led to the creation of patent-protected compounds that have the potential to revolutionize the treatment of fibrinolytic disorders. As he continues to push the boundaries of scientific discovery, Hamminga remains a trailblazer in the field of pharmaceutical inventions.

Is there anything else you would like to know about inventions or patents?

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…